Dr. Won Jin Ho presented a talk as part of the Immunology Neighborhood Seminar on “Overcoming the tumor immune ...

Elicio Therapeutics aims for breakthrough treatment with ELI-002 in pancreatic cancer. Find out why ELTX stock may benefit ...

Oncolytics Biotech® Inc. , a leading clinical-stage company specializing in immunotherapy for oncology, today provided details from the abstracts featuring pelareorep ...

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy characterized ... Demographic, clinical, and histological data, including tumor nodule metastasis stage, tumor grade ...

Even the healthiest of people get sick every now and then. But by fine-tuning certain aspects of your health routine, such as diet and stress management, you can help support your immune system's ...

LOAd703, an oncolytic adenovirus with transgenes for 4-1BBL and TMZ-CD40L, has received FDA fast track designation for ...

developing novel immune strategies will continue to play a critical role in designing effective treatment modalities for those at high risk of recurrence and those with distant metastasis.

These may be the words my oncologist used when he told me that I was now metastatic, but, to be honest, I can’t recall them clearly. What I can remember are the emotions: shock, disbelief ...

IBD falls under the umbrella of immune-mediated inflammatory diseases (IMIDs). Generally speaking, IMIDs are conditions in which chronic inflammation happens due to an atypical immune response.

About GOBLET Cohort 5 The mFOLFIRINOX cohort of the Phase 1/2 GOBLET study is designed to evaluate newly diagnosed metastatic PDAC patients ... inducing anti-cancer immune responses and promotes ...

Detailed price information for Oncolytics Biotech Inc (ONCY-Q) from The Globe and Mail including charting and trades.